We found 142 records for "Licensing / acquisition"

Articles

Selling science to potential investors and partners

12th September 2014

 Selling science to potential investors and partnersArticles

Start-ups and biotechs often need the support of outside investors to take their innovations to the next level. So what are the considerations when preparing a presentation for these important...

Read more

Adaptive Licensing: Could patients be the answer to the data problem?

4th August 2014

 Adaptive Licensing: Could patients be the answer to the data problem?Articles

Patients could play a key role in generating the data required to make Europe's Adaptive Licensing a success.The timing of patient access to new medicines has always been one of...

Read more

The trend to blend: M&A in pharma - Are you ready?

17th June 2014

 The trend to blend: M&A in pharma - Are you ready?Articles

Paul Gershlick and Laura Barrell examine the recent surge in mergers and acquisitions, and look at what small to medium sized firms can do to make themselves more attractive to...

Read more

UCB looks ahead to next phase

2nd June 2014

 UCB looks ahead to next phaseArticles

As UCB marks 10 years in the UK with a special event at its research centre in Slough, Andrew McConaghie talks to chief executive Roch Doliveux about the company's future.Ten...

Read more

News

Probiodrug IPO raises €22.5 million to fund Alzheimer’s candidates

24th October 2014

 Probiodrug IPO raises €22.5 million to fund Alzheimer’s candidates News

Probiodrug has successfully completed an Initial Public Offering (IPO) and will begin trading on Euronext Amsterdam on Monday 27 October at a share price of €15.25.The flotation raises €22.5 million...

Read more

AbbVie hits out at US Treasury as Shire bid dies

21st October 2014

 AbbVie hits out at US Treasury as Shire bid dies News

Following AbbVie's recommendation to its shareholders to vote against the takeover of Shire last week, Shire's board has agreed to terminate the Cooperation Agreement and release AbbVie from its obligations...

Read more

AbbVie withdraws Shire bid following US tax changes

16th October 2014

 AbbVie withdraws Shire bid following US tax changesNews

AbbVie's board has recommended its stockholders vote against its proposed £31 billion buyout of Shire as a result of the tightening of US tax laws in September to deter so-called...

Read more

Endo beats QLT to Auxilium merger

10th October 2014

 Endo beats QLT to Auxilium mergerNews

Endo International has persuaded Auxilium Pharma into a takeover that leaves an earlier plan to merge Auxilium with QLT in tatters.Ireland-based Endo has made a $2.6bn cash-and-stock offer for Auxilium...

Read more

White Papers

All change for pharma and biotech partnerships

30th September 2013

 All change for pharma and biotech partnershipsWhite Papers

The pharma industry is always evolving, and in the past decade, there has been an increasing reliance on partnering to strengthen R&D. In this original white paper, Phenestra shares its...

Read more

Events

2nd International Congress on Paragraph IV Litigation Strategy

29th October 2014 - 30th October 2014

2nd International Congress on Paragraph IV Litigation Strategy

Successful IP Litigation Strategies for Brand Name and Generic Manufacturers Imminent blockbuster patent expiration…new regulatory hurdles and procedural requirements created by the Biologics Price Competition and Innovation and America Invents Act…constantly...

Read more

Pharmaceutical Licensing and Collaboration Agreements: Legal Considerations

6th November 2014

Pharmaceutical Licensing and Collaboration Agreements: Legal Considerations

An in-depth review of the full process from structuring a deal through to termination provisions We have listened to your feedback! Extensive research was undertaken with leading industry experts from both in-house...

Read more

World Orphan Drug Congress Europe 2014

12th November 2014 - 14th November 2014

World Orphan Drug Congress Europe 2014

Europe’s leading commercial event for marrying industry research with patient advocacy; providing the platform for orphan drug developers, patient groups, payers and over 500 key rare disease stakeholders. It is...

Read more

Life Sciences IP Summit 2014

12th November 2014 - 14th November 2014

Life Sciences IP Summit 2014

An innovative new solution written in response to market demand, The Life Sciences IP Summit is a culmination of C5’s industry-leading portfolio of intellectual property events for the life sciences...

Read more